1
|
Ragshaniya A, Kumar V, Tittal RK, Lal K. Nascent pharmacological advancement in adamantane derivatives. Arch Pharm (Weinheim) 2024; 357:e2300595. [PMID: 38128028 DOI: 10.1002/ardp.202300595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2023] [Revised: 11/17/2023] [Accepted: 11/21/2023] [Indexed: 12/23/2023]
Abstract
The adamantane moiety has attracted significant attention since its discovery in 1933 due to its remarkable structural, chemical, and medicinal properties. This molecule has a notable impact in the therapeutic field because of its "add-on" lipophilicity to any pharmacophoric moieties. As in the case of molecular hybridization, in which one pharmacophore is attached to another one(s) with a probability of increasing the biological activity, adding an adamantane unit improves the absorption distribution, metabolism and excretion properties of the resultant hybrid molecule. This review summarizes various reports highlighting the biological activities of adamantane-based synthetic compounds and their structure-activity relationship study. The information presented in this review may open up possible dimensions for adamantane-based drug development and discovery in the pharmaceutical industry after proper structural modifications.
Collapse
Affiliation(s)
- Aman Ragshaniya
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| | - Vijay Kumar
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| | - Ram Kumar Tittal
- Department of Chemistry, National Institute of Technology, Kurukshetra, Haryana, India
| | - Kashmiri Lal
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| |
Collapse
|
2
|
Probing Adamantane Arylhydroxamic Acids against Trypanosoma brucei and Trypanosoma cruzi. MOLBANK 2022. [DOI: 10.3390/m1363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
In this work, we present the synthesis and the anti-trypanosomal activity of the 2-(4-(adamant-1-yl)phenyl)-N-hydroxyarylamides, 1a,b and the 2-(4-(adamant-1-yl)phenoxy)-N-hydroxyacetamide, 1c. The 4-(adamant-1-yl)phenyl- and 4-(adamant-1-yl)phenoxy- moieties, which are endowed with promising drug-like properties, are functionalized at the side chain termini as hydroxamic acids. The phenoxy acetohydroxamic derivative, 1c, shows the most interesting profile in terms of activity and toxicity against trypanosomes and merits further investigation.
Collapse
|
3
|
Shin NY, Ryss JM, Zhang X, Miller SJ, Knowles RR. Light -driven deracemization enabled by excited -state electron transfer. Science 2020; 366:364-369. [PMID: 31624212 DOI: 10.1126/science.aay2204] [Citation(s) in RCA: 139] [Impact Index Per Article: 34.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Accepted: 08/30/2019] [Indexed: 12/14/2022]
Abstract
Deracemization is an attractive strategy for asymmetric synthesis, but intrinsic energetic challenges have limited its development. Here, we report a deracemization method in which amine derivatives undergo spontaneous optical enrichment upon exposure to visible light in the presence of three distinct molecular catalysts. Initiated by an excited-state iridium chromophore, this reaction proceeds through a sequence of favorable electron, proton, and hydrogen-atom transfer steps that serve to break and reform a stereogenic C-H bond. The enantioselectivity in these reactions is jointly determined by two independent stereoselective steps that occur in sequence within the catalytic cycle, giving rise to a composite selectivity that is higher than that of either step individually. These reactions represent a distinct approach to creating out-of-equilibrium product distributions between substrate enantiomers using excited-state redox events.
Collapse
Affiliation(s)
- Nick Y Shin
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| | - Jonathan M Ryss
- Department of Chemistry, Yale University, New Haven, CT 06520, USA
| | - Xin Zhang
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| | - Scott J Miller
- Department of Chemistry, Yale University, New Haven, CT 06520, USA.
| | - Robert R Knowles
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
| |
Collapse
|
4
|
Georgiadis MO, Kourbeli V, Papanastasiou IP, Tsotinis A, Taylor MC, Kelly JM. Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. brucei. RSC Med Chem 2019; 11:72-84. [PMID: 33479605 PMCID: PMC7522794 DOI: 10.1039/c9md00478e] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Accepted: 11/22/2019] [Indexed: 01/10/2023] Open
Abstract
2-{2-[3-(1-Adamantyl)-4-fluorophenyl]thiazol-4-yl}ethan-1-amine (1a) and 2-{2-[4-(1-adamantyl)phenyl]thiazol-4-yl}ethan-1-amine (2a) exhibit activity against T. brucei in the range of IC50 = 0.42 μM and IC50 = 0.80 μM, respectively.
The design, synthesis and pharmacological evaluation of the 4-substituted-2-[3-(adamant-1-yl)-4-fluorophenyl]thiazoles 1a–j, the 4-substituted-2-[4-(adamant-1-yl)phenyl]thiazoles 2a–h, the 2-substituted-4-[4-(adamant-1-yl)phenyl]thiazoles 3a–e, the N-substituted 2-phenylthiazol-4-ethylamides 4a, b and the N-substituted 4-phenylthiazol-2-ethylamides 4c, d is described. Compounds 1a and 2a exhibit trypanocidal activity in the range of IC50 = 0.42 μM and IC50 = 0.80 μM, respectively. Both of these derivatives bear a lipophilic end, which consists of a 4-(1-adamantyl) phenyl or a 3-(1-adamantyl)phenyl moiety, a 1,3-thiazole ring and a functional end, which comprises of an alkylamine and can be considered as promising candidates for the treatment of Trypanosoma brucei infections.
Collapse
Affiliation(s)
- Markos-Orestis Georgiadis
- Division of Pharmaceutical Chemistry , Department of Pharmacy , School of Health Sciences , National and Kapodistrian University of Athens , Panepistimioupoli-Zografou , 157 84 Athens , Greece .
| | - Violeta Kourbeli
- Division of Pharmaceutical Chemistry , Department of Pharmacy , School of Health Sciences , National and Kapodistrian University of Athens , Panepistimioupoli-Zografou , 157 84 Athens , Greece .
| | - Ioannis P Papanastasiou
- Division of Pharmaceutical Chemistry , Department of Pharmacy , School of Health Sciences , National and Kapodistrian University of Athens , Panepistimioupoli-Zografou , 157 84 Athens , Greece .
| | - Andrew Tsotinis
- Division of Pharmaceutical Chemistry , Department of Pharmacy , School of Health Sciences , National and Kapodistrian University of Athens , Panepistimioupoli-Zografou , 157 84 Athens , Greece .
| | - Martin C Taylor
- Department of Pathogen Molecular Biology , London School of Hygiene and Tropical Medicine , Keppel Street , London WC1 E7HT , UK
| | - John M Kelly
- Department of Pathogen Molecular Biology , London School of Hygiene and Tropical Medicine , Keppel Street , London WC1 E7HT , UK
| |
Collapse
|
5
|
Synthesis, biology, computational studies and in vitro controlled release of new isoniazid-based adamantane derivatives. Future Med Chem 2019. [DOI: 10.4155/fmc-2019-0038] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Aim: There is a necessity for new drugs to be more efficient than today's standard due to the emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb) Results/methodology: 12 new isoniazid-based adamantane derivatives were synthesized and tested for their antitubercular activity. The pharmacological test results and the aqueous dissolution profile of representative examples of the new molecules are in agreement with the computational results obtained from docking poses and molecular dynamics simulations on the tested compounds. Conclusion: Among their congeners, the adamantane isonicotinoyl hydrazones Ia and Ih exhibit the best antitubercular activity (MIC = 0.04 μg/ml) and the lowest cytotoxicity (selectivity index ≥2500). These results are useful for in future in vivo studies.
Collapse
|
6
|
Vlachou M, Papanastasiou IP, Georgiadis M, Tsakoumagkou A, Siskos Z, Siamidi A, Konstantinou A, Vocat A, Cole ST. Design, Synthesis and
in vitro
Controlled Release of New Adamantanodiarylketone Antimycobacterials. ChemistrySelect 2019. [DOI: 10.1002/slct.201902283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Marilena Vlachou
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Ioannis P. Papanastasiou
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Markos‐Orestis Georgiadis
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Argyro Tsakoumagkou
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Zacharias Siskos
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Angeliki Siamidi
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Anna Konstantinou
- School of Health SciencesDepartment of PharmacyDivision of Pharmaceutical ChemistryNational and Kapodistrian University of Athens, Panepistimioupoli-Zografou 157 84 Athens Greece
| | - Anthony Vocat
- Global Health InstituteÉcole Polytechnique Fédérale de Lausanne Station 19 1015 Lausanne Switzerland
| | - Stewart T. Cole
- Global Health InstituteÉcole Polytechnique Fédérale de Lausanne Station 19 1015 Lausanne Switzerland
- Institut Pasteur 25-28 rue du Docteur Roux 75724 Paris Cedex 15 France
| |
Collapse
|
7
|
Foscolos AS, Papanastasiou I, Tsotinis A, Taylor MC, Kelly JM. Synthesis and Evaluation of Nifurtimox-Adamantane Adducts with Trypanocidal Activity. ChemMedChem 2019; 14:1227-1231. [PMID: 31066972 DOI: 10.1002/cmdc.201900165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2019] [Revised: 04/11/2019] [Indexed: 11/08/2022]
Abstract
The synthesis and pharmacological evaluation of C1-substituted adamantane hydrazones, their C2-substituted isomers, and C1-substituted adamantane furanoic carboxamides is described. These new adamantane derivatives exhibited an interesting pharmacological profile in terms of trypanocidal activity and selectivity. The most active adduct with the best selectivity in this study was found to be the phenylacetoxy hydrazone 1 b (2-[4-(tricyclo[3.3.1.13,7 ]dec-1-yl)phenyl]-N'-[(5-nitrofuran-2-yl)methylene]acetohydrazide; EC50 =11±0.9 nm, SITb =770).
Collapse
Affiliation(s)
- Angeliki-Sofia Foscolos
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84, Athens, Greece
| | - Ioannis Papanastasiou
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84, Athens, Greece
| | - Andrew Tsotinis
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84, Athens, Greece
| | - Martin C Taylor
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1 E7HT, UK
| | - John M Kelly
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1 E7HT, UK
| |
Collapse
|
8
|
Georgiadis MO, Kourbeli V, Ioannidou V, Karakitsios E, Papanastasiou I, Tsotinis A, Komiotis D, Vocat A, Cole ST, Taylor MC, Kelly JM. Synthesis of diphenoxyadamantane alkylamines with pharmacological interest. Bioorg Med Chem Lett 2019; 29:1278-1281. [PMID: 30981579 DOI: 10.1016/j.bmcl.2019.04.010] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Revised: 04/02/2019] [Accepted: 04/05/2019] [Indexed: 01/31/2023]
Abstract
In this work, the synthesis and the pharmacological evaluation of diphenoxyadamantane alkylamines Ia-f and IIa-f is described. The new diphenoxy-substituted adamantanes share structural features present in trypanocidal and antitubercular agents. 1-Methylpiperazine derivative Ia is the most potent against T. brucei compound, whilst its hexylamine congener IIf exhibits a significant antimycobacterial activity.
Collapse
Affiliation(s)
- Markos-Orestis Georgiadis
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece
| | - Violeta Kourbeli
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece
| | - Vaya Ioannidou
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece
| | - Evangelos Karakitsios
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece
| | - Ioannis Papanastasiou
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece.
| | - Andrew Tsotinis
- School of Health Sciences, Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157 84 Athens, Greece
| | - Dimitri Komiotis
- Department of Biochemistry and Biotechnology, Laboratory of Bioorganic Chemistry, University of Thessaly, 41221 Larissa, Greece
| | - Anthony Vocat
- Global Health Institute, École Polytechnique Fédérale de Lausanne, Station 19, 1015 Lausanne, Switzerland
| | - Stewart T Cole
- Global Health Institute, École Polytechnique Fédérale de Lausanne, Station 19, 1015 Lausanne, Switzerland; Institut Pasteur, 25-28 rue du Docteur Roux, 75724 Paris Cedex 15, France
| | - Martin C Taylor
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 E7HT, UK
| | - John M Kelly
- Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 E7HT, UK
| |
Collapse
|
9
|
Sączewski F, Kornicka A, Balewski Ł. Imidazoline scaffold in medicinal chemistry: a patent review (2012–2015). Expert Opin Ther Pat 2016; 26:1031-48. [DOI: 10.1080/13543776.2016.1210128] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
10
|
Foscolos AS, Papanastasiou I, Foscolos GB, Tsotinis A, Kellici TF, Mavromoustakos T, Taylor MC, Kelly JM. New hydrazones of 5-nitro-2-furaldehyde with adamantanealkanohydrazides: synthesis and in vitro trypanocidal activity. MEDCHEMCOMM 2016. [DOI: 10.1039/c6md00035e] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A range of hydrazones of 5-nitro-2-furaldehyde with adamantane alkanohydrazides was synthesized and their trypanocidal activity was evaluated.
Collapse
Affiliation(s)
- Angeliki-Sofia Foscolos
- School of Health Sciences
- Faculty of Pharmacy
- Department of Pharmaceutical Chemistry
- National and Kapodistrian University of Athens
- 15784 Athens
| | - Ioannis Papanastasiou
- School of Health Sciences
- Faculty of Pharmacy
- Department of Pharmaceutical Chemistry
- National and Kapodistrian University of Athens
- 15784 Athens
| | - George B. Foscolos
- School of Health Sciences
- Faculty of Pharmacy
- Department of Pharmaceutical Chemistry
- National and Kapodistrian University of Athens
- 15784 Athens
| | - Andrew Tsotinis
- School of Health Sciences
- Faculty of Pharmacy
- Department of Pharmaceutical Chemistry
- National and Kapodistrian University of Athens
- 15784 Athens
| | - Tahsin F. Kellici
- Faculty of Chemistry
- Department of Organic Chemistry
- University of Athens
- 15771 Athens
- Greece
| | - Thomas Mavromoustakos
- Faculty of Chemistry
- Department of Organic Chemistry
- University of Athens
- 15771 Athens
- Greece
| | - Martin C. Taylor
- Department of Pathogen Molecular Biology
- London School of Hygiene and Tropical Medicine
- London WC1 E7HT
- UK
| | - John M. Kelly
- Department of Pathogen Molecular Biology
- London School of Hygiene and Tropical Medicine
- London WC1 E7HT
- UK
| |
Collapse
|
11
|
Dong Y, Wang X, Cal M, Kaiser M, Vennerstrom JL. Activity of diimidazoline amides against African trypanosomiasis. Bioorg Med Chem Lett 2014; 24:944-8. [PMID: 24398295 DOI: 10.1016/j.bmcl.2013.12.064] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Revised: 12/14/2013] [Accepted: 12/16/2013] [Indexed: 11/28/2022]
Abstract
We identified several diimidazoline mono- and diamides that were as potent as pentamidine against Trypanosoma brucei rhodesiense in vitro. All of these were also less cytotoxic than pentamidine, but none was as effective as the latter in a T. brucei rhodesiense-infected mouse model. A single imidazoline may be sufficient for high antitrypanosomal activity provided that a second weak base functional group is present.
Collapse
Affiliation(s)
- Yuxiang Dong
- College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE, USA
| | - Xiaofang Wang
- College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE, USA
| | - Monica Cal
- Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland; University of Basel, CH-4003 Basel, Switzerland
| | - Marcel Kaiser
- Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland; University of Basel, CH-4003 Basel, Switzerland
| | - Jonathan L Vennerstrom
- College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE, USA.
| |
Collapse
|